9Virtanen HE,Tapanainen AE,Kaleva MM,et al.Mild gesrational diabetes as a risk factor for congenital cryptorchidism[J].J CLin Endocrinol metab,2006,91(12):4862-4865.
10Barthold JS.Undescended testis.,current theories of etiology[J].Curr Opin Urol,2008,18(4):395-400.
二级参考文献24
1Franck-Lissbrant I, Haggestrom S, Damber JE, et al. Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats[J]. Endocrinology, 1998, 139:451.
2Weingartner K, Ben-Sasson SA, Stewart R, et al. Endothelial cell proliferation activity in benign prostatic hyperplasia andprostate cancer: an in vitro model for assessment[J]. J Urol,1998, 159:465-470.
3Martin C, Michel, et al. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia[J].J Urol, 2000, 163:1725-1729.
4Hammarsten J, Hogstedt B. Clincal, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia[J]. Blood Pressure, 1998, 8:29-36.
5Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer[J] . Int J Cancer, 1997,74:64 - 68.
6Welder N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma[J]. J Natl Cancer Inst, 1992, 84:1875-1882.
7Bailey DM, Foley SJ. Microvascular anatomy in patients with recurrent haematuria related to prostatic hypertrophy[J]. J Urol, 1999, 161:225.
8Marshall S, Narayan P. Treatment of prostatic bleeding: suppression of angiogenesis by androgen deprivation[J]. J Urol,1993, 149(6): 1553 - 1554.
9Collins AJ, Kasiske B, Herzog C, et al. United States renal data system 2006 annual data report abstract. Am J Kidney Dis, 2007,49 ( 1 Suppl 1 ) : A6-7.
10Centers for Disease Control and Prevention (CDC). Incidence of end-stage renal disease among persons with diabetes--United States, 1990-2002. MMWR Morb Mortal Wkly Rep,2005,54:1097-1100.
